| Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication CJ Landmark, A Baftiu, I Tysse, B Valsø, PG Larsson, E Rytter, ... Therapeutic drug monitoring 34 (4), 440-445, 2012 | 105 | 2012 |
| Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders—a pharmacoepidemiological study and clinical implications A Baftiu, C Johannessen Landmark, IR Rusten, SA Feet, SI Johannessen, ... European journal of clinical pharmacology 72, 1245-1254, 2016 | 66 | 2016 |
| Therapeutic drug monitoring of lacosamide in Norway: focus on pharmacokinetic variability, efficacy and tolerability T Svendsen, E Brodtkorb, A Baftiu, ML Burns, SI Johannessen, ... Neurochemical research 42, 2077-2083, 2017 | 52 | 2017 |
| Withdrawal of antiepileptic drugs during presurgical video‐EEG monitoring: an observational study for evaluation of current practice at a referral center for epilepsy O Henning, A Baftiu, SI Johannessen, CJ Landmark Acta Neurologica Scandinavica 129 (4), 243-251, 2014 | 47 | 2014 |
| Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice CJ Landmark, G Beiske, A Baftiu, ML Burns, SI Johannessen Seizure 28, 88-91, 2015 | 43 | 2015 |
| Association between antiseizure drug monotherapy and mortality for patients with poststroke epilepsy D Larsson, A Baftiu, CJ Landmark, M von Euler, E Kumlien, S Åsberg, ... JAMA neurology 79 (2), 169-175, 2022 | 38 | 2022 |
| Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: a pharmacoepidemiological study of CNS-active drugs in Norway … A Baftiu, SA Feet, PG Larsson, ML Burns, O Henning, E Sætre, E Molden, ... Epilepsy research 139, 35-42, 2018 | 38 | 2018 |
| Discrepancies between physicians' prescriptions and patients' use of antiepileptic drugs M Mevaag, O Henning, A Baftiu, AG Granas, SI Johannessen, KO Nakken, ... Acta Neurologica Scandinavica 135 (1), 80-87, 2017 | 34 | 2017 |
| Therapeutic drug monitoring of clobazam and its metabolite—impact of age and comedication on pharmacokinetic variability ML Burns, A Baftiu, MS Opdal, SI Johannessen, CJ Landmark Therapeutic Drug Monitoring 38 (3), 350-357, 2016 | 33 | 2016 |
| The impact of pharmacokinetic interactions with eslicarbazepine acetate versus oxcarbazepine and carbamazepine in clinical practice CJ Landmark, T Svendsen, J Dinarevic, RF Kufaas, A Reimers, ... Therapeutic Drug Monitoring 38 (4), 499-505, 2016 | 27 | 2016 |
| Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy CJ Landmark, I Fløgstad, M Syvertsen, A Baftiu, U Enger, J Koht, ... Epilepsy & Behavior 98, 110-116, 2019 | 22 | 2019 |
| Pharmacokinetic variability of valproate during pregnancy–implications for the use of therapeutic drug monitoring CJ Landmark, AH Farmen, ML Burns, A Baftiu, MI Lossius, ... Epilepsy Research 141, 31-37, 2018 | 21 | 2018 |
| Pharmacokinetic variability of valproate in women of childbearing age C Johannessen Landmark, ML Burns, A Baftiu, AH Farmen, MI Lossius, ... Epilepsia 58 (10), e142-e146, 2017 | 20 | 2017 |
| Availability of antiepileptic drugs across Europe A Baftiu, C Johannessen Landmark, V Nikaj, IL Neslein, SI Johannessen, ... Epilepsia 56 (12), e191-e197, 2015 | 18 | 2015 |
| Long-term follow-up with therapeutic drug monitoring of antiepileptic drugs in patients with juvenile myoclonic epilepsy CJ Landmark, I Fløgstad, A Baftiu, M Syvertsen, U Enger, J Koht, ... Epilepsy research 155, 106148, 2019 | 16 | 2019 |
| Safety aspects of antiepileptic drugs—a population-based study of adverse effects relative to changes in utilisation A Baftiu, MH Lima, K Svendsen, PG Larsson, SI Johannessen, ... European Journal of Clinical Pharmacology 75, 1153-1160, 2019 | 14 | 2019 |
| Pharmacokinetic variability and clinical use of lacosamide in children and adolescents in Denmark and Norway ML Burns, M Nikanorova, A Baftiu, JB Rasmussen, SI Johannessen, ... Therapeutic drug monitoring 41 (3), 340-347, 2019 | 13 | 2019 |
| Valproat er kontraindisert ved graviditet DB Olsen, A Baftiu Tidsskrift for Den norske legeforening, 2019 | 4 | 2019 |
| Erratum to: Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders—A pharmacoepidemiological study and clinical implications A Baftiu, CJ Landmark, IR Rusten, SA Feet, SI Johannessen, PG Larsson European Journal of Clinical Pharmacology 73, 791-792, 2017 | 4 | 2017 |
| Clinical experience combined with therapeutic drug monitoring of lacosamide T Svendsen, E Brodtkorb, A Baftiu, MI Lossius, KO Nakken, ... Acta Neurologica Scandinavica 141 (4), 279-286, 2020 | 3 | 2020 |
